Post-translational modification by SUMO

Toxicology

Volumn 278, Issue 3, 2010, Pages 288-293

  Hannoun, Zara ^a   Greenhough, Sebastian ^a   Jaffray, Ellis ^b   Hay, Ronald T ^b   Hay, David C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cell biology; Post translational modification; SUMO

Indexed keywords

SUMO PROTEIN;

CELL CYCLE REGULATION; CELLULAR DISTRIBUTION; ECTODERM; EMBRYONIC STEM CELL; ENDODERM; GENETIC TRANSCRIPTION; HUMAN; MESODERM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SOMATIC CELL; SUMOYLATION;

EMBRYONIC STEM CELLS; HUMANS; SUMO-1 PROTEIN; SUMOYLATION;

EID: 78649753221     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.07.013     Document Type: Review

References (66)

1. Azuma Y., Tan S.H., Cavenagh M.M., Ainsztein A.M., Saitoh H., Dasso M. Expression and regulation of the mammalian SUMO-1 E1 enzyme. FASEB J. 2001, 15:1825-1827.
2. Barberis A., Sachidhanandam S., Mulle C. GluR6/KA2 kainate receptors mediate slow-deactivating currents. J. Neurosci. 2008, 28:6402-6406.
3. Benson M.D., Li Q.J., Kieckhafer K., Dudek D., Whorton M.R., Sunahara R.K., Iñiguez-Lluhí J.A., Martens J.R. SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:1805-1810.
4. Biggers J.D., Borland R.M. Physiological aspects of growth and development of the preimplantation mammalian embryo. Annu. Rev. Physiol. 1976, 38:95-119.
5. Burnett G., Kennedy E.P. The enzymatic phosphorylation of proteins. J. Biol. Chem. 1954, 211:969-980.
6. Cai J., Chen J., Liu Y., Miura T., Luo Y., Loring J.F., Freed W.J., Rao M.S., Zeng X. Assessing self renewal and differentiation in hESC Lines. Stem Cells 2006, 24(3):516-530.
7. Desterro J.M., Rodriguez M.S., Hay R.T. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell. 1998, 2:233-239.
8. Desterro J.M., Thomson J., Hay R.T. Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 1997, 417:297-300.
9. Fletcher J., Cui W., Samuel K., Black J.R., Hannoun Z., Currie I.S., Terrace J.D., Payne C., Filippi C., Newsome P., Forbes S.J., Ross J.A., Iredale J.P., Hay D.C. The inhibitory role of stromal cell mesenchyme on human embryonic stem cell hepatocyte differentiation is overcome by Wnt3a treatment. Cloning Stem Cells 2008, 10:331-339.
10. Frazier A.E., Kiu C., Stojanovski D., Hoogenraad N.J., Ryan M.T. Mitochondrial morphology and distribution in mammalian cells. Biol. Chem. 2006, 387:1551-1558.
11. Glozak M.A., Sengupta N., Zhang X., Seto E. Acetylation and deacetylation of non-histone proteins. Gene 2005, 363:15-23.
12. Grewal S.I.S., Rice J.C. Regulation of heterochromatin by histone methylation and small RNAs. Curr. Opin. Cell Biol. 2004, 16:230-238.
13. Hannoun Z., Filippi C., Sullivan G., Hay D.C., Iredale J.P. Hepatic endoderm differentiation from human embryonic stem cells. Curr. Stem Cell Res. Ther. 2010.
14. Hannoun Z., Fletcher J., Greenhough S., Medine C., Samuel K., Sharma R., Pryde A., Black J., Ross J., Wilmut I., Iredale J., Hay D. The comparison between conditioned media and serum-free media in human embryonic stem cell culture and differentiation. Cell. Reprog. 2010, 12:133-140.
15. Harder Z., Zunino R., McBride H. Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission. Curr. Biol. 2004, 14:340-345.
16. Hardeland U., Steinacher R., Jiricny J., Schär P. Modification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnover. EMBO J. 2002, 21:1456-1464.
17. Hay D.C., Fletcher J., Payne C., Terrace J.D., Gallagher R.C.J., Snoeys J., Black J.R., Wojtacha D., Samuel K., Hannoun Z., Pryde A., Filippi C., Currie I.S., Forbes S.J., Ross J.A., Newsome P.N., Iredale J.P. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:12301-12306.
18. Hay D.C., Sutherland L., Clark J., Burdon T. Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells 2004, 22:225-235.
19. Hayashi T., Seki M., Maeda D., Wang W., Kawabe Y.I., Seki T., Saitoh H., Fukagawa T., Yagi H., Enomoto T. Ubc9 is essential for viability of higher eukaryotic cells. Exp. Cell Res. 2002, 280:212-221.
20. Hietakangas V., Anckar J., Blomster H.A., Fujimoto M., Palvimo J.J., Nakai A., Sistonen L. PDSM, a motif for phosphorylation-dependent SUMO modification. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:45-50.
21. Hochstrasser M. SP-RING for SUMO: new functions bloom for a ubiquitin-like protein. Cell 2001, 107:5-8.
22. Hong Y., Rogers R., Matunis M.J., Mayhew C.N., Goodson M.L., Park-Sarge O.K., Sarge K.D., Goodson M. Regulation of heat shock transcription factor 1 by stress-induced SUMO-1 modification. J. Biol. Chem. 2001, 276:40263-40267.
23. Hoof D.V., Javier M., Stefan R.B., Pinkse M.W.H., Linding R., Heck A.J.R., Mummery C.L., Krijgsveld J. Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 2009, 5:214-226.
24. Johnson E.S., Schwienhorst I., Dohmen R.J., Blobel G. The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J. 1997, 16:5509-5519.
25. Johnson E.S. Protein modification by SUMO. Annu. Rev. Biochem. 2004, 73:355-382.
26. Kagey M.H., Melhuish T.A., Wotton D. The polycomb protein Pc2 is a SUMO E3. Cell 2003, 113:127-137.
27. Kang X., Qi Y., Zuo Y., Wang Q., Zou Y., Schwartz R.J., Cheng J., Yeh E.T.H. SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development. Mol. Cell 2010, 38(2):191-201.
28. Kroetz M.B. SUMO: a ubiquitin-like protein modifier. Yale J. Biol. Med. 2005, 78:197-201.
29. Lagrutta A., Wang J., Fermini B., Salata J.J. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current. J. Pharm. Exp. Ther. 2006, 317(3):1054-1063.
30. Lin X., Sun B., Liang M., Liang Y.Y., Gast A., Hildebrand J., Brunicardi F.C., Melchior F., Feng X.H. Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol. Cell 2003, 11:1389-1396.
31. Liu B., Liao J., Rao X., Kushner S.A., Chung C.D., Chang D.D., Shuai K. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:10626-10631.
32. Martin S., Nishimune A., Mellor J.R., Henley J.M. SUMOylation regulates kainate-receptor-mediated synaptic transmission. Nature 2007, 447:321-325.
33. McKinsey T.A., Zhang C.L., Olson E.N. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem. Sci. 2002, 27:40-47.
34. Melchior F., Schergaut M., Pichler A. SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem. Sci. 2003, 28:612-618.
35. Mukhopadhyay D., Dasso M. Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 2007, 32:286-295.
36. Müller S., Hoege C., Pyrowolakis G., Jentsch S. SUMO, ubiquitin's mysterious cousin. Nat. Rev. Mol. Cell Biol. 2001, 2:202-210.
37. Mziaut H., Trajkovski M., Kersting S., Ehninger A., Altkrüger A., Lemaitre R.P., Schmidt D., Saeger H.D., Lee M.S., Drechsel D.N., Müller S., Solimena M. Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5. Nat. Cell Biol. 2006, 8:435-445.
38. Nacerddine K., Lehembre F., Bhaumik M., Artus J., Cohen-Tannoudji M., Babinet C., Pandolfi P.P., Dejean A. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev. Cell 2005, 9:769-779.
39. Nasu-Nishimura Y., Jaffe H., Isaac J.T.R., Roche K.W. Differential regulation of kainate receptor trafficking by phosphorylation of distinct sites on GluR6. J. Biol. Chem. 2010, 285:2847-2856.
40. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., Schöler H., Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998, 95:379-391.
41. Nishimoto T. A new role of ran GTPase. Biochem. Biophys. Res. Commun. 1999, 262:571-574.
42. Nowak M., Hammerschmidt M. Ubc9 regulates mitosis and cell survival during zebrafish development. Mol. Biol. Cell 2006, 17:5324-5336.
43. Orford K., Crockett C., Jensen J.P., Weissman A.M., Byers S.W. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J. Biol. Chem. 1997, 272:24735-24738.
44. Pedersen T.A., Kowenz-Leutz E., Leutz A., Nerlov C. Cooperation between C/EBPalpha TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiation. Genes Dev. 2001, 15:3208-3216.
45. Pelton T.A., Bettess M.D., Lake J., Rathjen J., Rathjen P.D. Developmental complexity of early mammalian pluripotent cell populations in vivo and in vitro. Reprod. Fertil. Dev. 1998, 10:535-549.
46. Pichler A., Gast A., Seeler J.S., Dejean A., Melchior F. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 2002, 108:109-120.
47. Rytinki M.M., Kaikkonen S., Pehkonen P., Jääskeläinen T., Palvimo J.J. PIAS proteins: pleiotropic interactors associated with SUMO. Cell Mol. Life Sci. 2009, 66:3029-3041.
48. Saitoh H., Pu R., Cavenagh M., Dasso M. RanBP2 associates with Ubc9p and a modified form of RanGAP1. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:3736-3741.
49. Sato Y., Miyake K., Kaneoka H., Iijima S. Sumoylation of CCAAT/enhancer-binding protein alpha and its functional roles in hepatocyte differentiation. J. Biol. Chem. 2006, 281:21629-21639.
50. Schmidt D., Müller S. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:2872-2877.
51. Seeler J.S., Dejean A. Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 2003, 4:690-699.
52. Shalizi A., Gaudillière B., Yuan Z., Stegmüller J., Shirogane T., Ge Q., Tan Y., Schulman B., Harper J.W., Bonni A. A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science 2006, 311:1012-1017.
53. Spiro R.G. Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 2002, 12:43-56.
54. Sternsdorf T., Jensen K., Reich B., Will H. The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 1999, 274:12555-12566.
55. Takahashi Y., Toh-e A., Kikuchi Y. A novel factor required for the SUMO1/Smt3 conjugation of yeast septins. Gene 2001, 275:223-231.
56. Tam P.P.L., Kanai-Azuma M., Kanai Y. Early endoderm development in vertebrates: lineage differentiation and morphogenetic function. Curr. Opin. Genet. Dev. 2003, 13:393-400.
57. Tatham M.H., Geoffroy M.C., Shen L., Plechanovova A., Hattersley N., Jaffray E.G., Palvimo J.J., Hay R.T. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 2008, 10:538-546.
58. Twig G., Hyde B., Shirihai O.S. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim. Biophys. Acta 2008, 1777:1092-1097.
59. Ulrich H.D. The SUMO system: an overview. Methods Mol. Biol. 2009, 497:3-16.
60. Verger A., Perdomo J., Crossley M. Modification with SUMO. A role in transcriptional regulation. EMBO Rep. 2003, 4:137-142.
61. Waby J.S., Bingle C.D., Corfe B.M. Post-translational control of sp-family transcription factors. Curr. Genomics 2008, 9:301-311.
62. Walden H., Podgorski M.S., Schulman B.A. Insights into the ubiquitin transfer cascade from the structure of the activating enzyme for NEDD8. Nature 2003, 422:330-334.
63. Walsh C.T., Garneau-Tsodikova S., Gatto G.J. Protein posttranslational modifications: the chemistry of proteome diversifications. Angew. Chem. Int. Ed. Engl. 2005, 44:7342-7372.
64. Wang J., Feng X.H., Schwartz R.J. SUMO-1 modification activated GATA4-dependent cardiogenic gene activity. J. Biol. Chem. 2004, 279:49091-49098.
65. Wei F., Schöler H.R., Atchison M.L. Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. J. Biol. Chem. 2007, 282:21551-21560.
66. Zunino R., Schauss A., Rippstein P., Navarro M.A., McBride H.M. The SUMO protease SENP5 is required to maintain mitochondrial morphology and function. J. Cell Sci. 2007, 120:1178-1188.